V. B. Dukhnytskyi

V. B. Dukhnytskyi

Auto-generated profile, based on publicly available information

V. B. Dukhnytskyi

National University of Life and Environmental Sciences of Ukraine, Kyiv, Ukraine

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2022 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VSV. M. Sokoliuk
V. M. Sokoliuk
VDV. B. Dukhnytsky
V. B. Dukhnytsky
TKT. V. Krupelnytsky
T. V. Krupelnytsky
ILI. P. Ligomina
I. P. Ligomina
ARA. S. Revunets
A. S. Revunets
VPV. M. Prus
V. M. Prus
The article presents a study of the organization of milk production technology on the farm with tethered and tethered-boxing of cows. It has been established that one of the departments uses Dairy Plan C21 herd management software. This makes it possible to obtain comprehensive data on milk productivity, health, and behavior of each cow, group of animals, and the herd. Pre- and post-milking treatment of cows' teats with means based on a probiotic culture of Bacillus subtilis, Forticept® Udder Wash, and Zooprotect. According to the research results, data on production and sales were obtained, and indicators of quality and safety of whole raw milk from two departments were analyzed. Gross milk production for the year at section 1 with free-range boxing of cows was 1875.4 tons, the average annual yield per cow – 7381 kg, milk marketability – 96.3 %. The production figures for section № 2 with tethered animals were – 1324.2 tons, 7333 kg, and 96.5 %, respectively. The study found that the average annual amount of MAFANM in milk from cows at tethered housing was 37 ± 3.6 × 104 thousand CFU/cm3; loose-box – 35 ± 4.1 × 104 thousand CFU/m3; the number of somatic cells is 327.8 ± 28.73 and 332.1 ± 29.91 thousand cm3, respectively. In the milk of cows from section № 2 the protein content was 3.19 ± 0.067 %, fat – 3.78 ± 0.106 %, fat/protein ratio – 1.18 : 1. Slightly higher values were obtained when studying cows' milk from the sections № 1 – 3.22 ± 0.033; 3.88 ± 0.093 %, and 1.21 : 1, respectively. According to normative indicators, the fat/protein ratio is 1.2–1.4 : 1. It should be noted that deviations from these indicators indicate a violation of metabolic processes in cows. Indicators of acidity and density in cow's milk were within the normative values. According to research, no heavy metals, pesticides, radionuclides, or inhibitors have been detected in whole raw milk. Therefore, analyzing the data obtained, it should be noted that the milk produced on the farm and sold to processing enterprises meets the requirements for quality milk. According to the national standard, it is suitable for producing quality and safe products.

16 August 2023 in Ukrainian Journal of Veterinary and Agricultural Sciences
Verified
Journal Article
Open access
PDF file
ІLІ. P. Ligomina
І. P. Ligomina
VSV. M. Sokolyuk
V. M. Sokolyuk
ISI. M. Sokulskyi
I. M. Sokulskyi
BGBogdan Gutyj
Bogdan Gutyj
VDV. B. Dukhnytskyi
V. B. Dukhnytskyi
Today, one of the priority tasks in animal husbandry and veterinary medicine is the creation of a highly productive, stable herd with a stable level of metabolism. A large load on the animal's body reveals high milk productivity; in connection with this, metabolic processes slow down, directly reducing milk productivity and requiring a balanced diet and high-quality feed. An increase in milk productivity is often directly related to metabolic disorders and the appearance of diseases, including the intensity of physiological and biochemical metabolic processes associated with converting a significant amount of energy and nutrients from feed into milk. Metabolic pathologies in animals can be caused by hereditary defects in the metabolism of nucleic acids, congenital insufficiency of enzymes responsible for the synthesis and breakdown of amino acids, disorders of organic acid metabolism, fatty acid deficiency, etc. Timely diagnosis of rickets and rapid therapy in the initial period is essential in treatment because the earlier the diagnosis is made, the easier it is to treat the disease. This will lead to the termination of the further destructive process, the occurrence of bone deformations, and changes in internal organs. The article deals with the issue of vitamin D deficiency in young cattle from a modern perspective. Materials on the classification, etiology, and pathogenesis of vitamin D-deficient rickets in calves are covered. The role of vitamin D in the prevention of rickets and its importance for general animal health and welfare are summarized. It is noted that this disease's characteristic feature is mainly the course's hidden stages. Clinical symptoms of D-hypovitaminosis appear in the late stages of the disease when restoring the animal's health is impossible. The essence of the pathology is a violation of mineralization of the organic matrix of bone tissues (D-hypovitaminosis) or osteolysis of already formed structures. The work aimed to find out the distribution, etiology, biochemical and clinical manifestation of D-hypovitaminosis in calves in one of the farms of the northern districts of Zhytomyr region, which belongs to the natural-geographical zone of Zhytomyr Polissia. The material for the study was clinically healthy calves and calves with rickets aged 1–3 months. The conditions of keeping and feeding animals on the farm were studied. Diagnosis and spread of D-hypovitaminosis among calves 1–3 months old were carried out with the help of clinical and unique methods; first, preference was given to laboratory studies. Clinical manifestations are described, and laboratory features of the course of vitamin D deficiency in animals are presented. It has been established that vitamin D deficiency in calves is quite widespread on the farm. Thus, the subclinical (hidden) course was registered in 45.8 % of animals and the clinical – in 24.1 %. The disease was more often registered in the winter-spring period. The leading cause of the disease in calves is insufficient motor activity (hypodynamia) in the absence of insolation, as well as a low level of feeding: reduced provision of cholecalciferol (25.8 %), violation of the calcium-phosphorus ratio (2.7–4.2:1 versus 1.5–2.0:1), deficiency of microelements – cobalt, zinc, copper, the provision of which was, respectively, 57.6, 85.6 and 96.2 % of the need. Pathognomotic manifestations of the disease in calves are licking, allotriophagia, thickening of carpal joints, partial resorption of the last ribs and tail vertebrae, and loose teeth. Vitamin D deficiency prevents the efficient absorption of calcium and phosphorus in feed. With vitamin D deficiency, only 10–15 % of feed calcium and 50–60 % of phosphorus are absorbed. The most informative laboratory markers for diagnosing pathology are determining cholecalciferol content, total calcium, inorganic phosphorus, alkaline phosphatase activity, and its bone isoenzyme in blood serum.

15 March 2025 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VDV. B. Dukhnytskyi
V. B. Dukhnytskyi
LGL. P. Goralskyi
L. P. Goralskyi
VSV. M. Sokoliuk
V. M. Sokoliuk
BGBogdan Gutyj
Bogdan Gutyj
NKN. L. Kolesnik
N. L. Kolesnik
VPV. S. Pykaliuk
V. S. Pykaliuk
Neonicotinoids are a new class of synthetic insecticides developed based on nicotine's structure to protect many crops from harmful insects. The article presents the results of studies of morphological changes in the organs of laying hens during chronic experimental poisoning with a neonicotinoid - Aktara 25 WG. Chronic poisoning with Aktara 25 WG was reproduced by feeding compound feed treated with this drug in doses calculated in mg of active ingredient per 1 kg of body weight. The birds of the first group served as controls and received compound feed without additives. Chickens of the first experimental group were fed compound feed containing the drug Aktara 25 WG at a dose of 360 mg/kg b.w., and chickens of the second experimental group consumed compound feed containing 180 mg/kg b.w. of the drug Aktara 25 WG. It was found that feeding laying hens with feed containing Aktara 25 WG in different doses for 30 days leads to an increase in the spleen mass coefficient, a decrease in the heart and liver mass coefficients. Feeding feed with Aktara 25 WG caused a reduction in the relative mass coefficient of the liver and the muscular part of the stomach in laying hens of the experimental groups, the results of which significantly correlate with the absolute mass indicators of the corresponding organs and are direct evidence of the toxic effect of the insecticide “Aktara 25 WG” on the animal body, where the digestive organs react first of all. In the chickens of the first experimental group, dystrophic-necrobiotic changes are observed in the liver, round-cell infiltration of the portal tracts; in the kidneys – dystrophic-necrobiotic changes in the epithelial cells of the renal tubules; in the myocardium – granular dystrophy of cardiomyocytes, capillary hyperemia, stasis and edema of the stroma; in the brain – pericellular edema; in the stomach – mucous dystrophy, desquamation of the mucosal epithelium, decrease in lymphocytes in lymphoid structures, atrophy of the epithelium of glandular structures; in the small intestine – hyperemia and necrosis of the apical part of the villi, round cell infiltration in the crypt area; in the colon – proliferation of cellular elements of the connective tissue between the crypts.

27 July 2023 in Online Journal of Animal and Feed Research
Verified
Journal Article
Closed access
IDIryna Derkach
Iryna Derkach
SDSerhii Derkach
Serhii Derkach
VDVolodymyr Dukhnytskyi
Volodymyr Dukhnytskyi
ОVОleksandr Valchuk
Оleksandr Valchuk
YZYurii Zhuk
Yurii Zhuk
MGMykola Gruntovskyi
Mykola Gruntovskyi
Antianemic drugs are used to prevent anemia, majorly iron deficiency anemia. Drugs with such pharmacological action are especially relevant for piglets, as animals of this species at this age are particularly sensitive to iron deficiency. The present investigation aimed at studying the pharmaceutical market of antianemic drugs registered in Ukraine during 2017-2022. It should be noted that if the drug is registered, it has been checked for safety according to the food industry standards of Ukraine. In 2017, the national market of veterinary iron-containing drugs was represented by 13 drugs from the group QB03A “Antianemic drugs. Drugs of iron”, according to the АТС-vet classification. The range of these drugs by 38 % was provided by pharmaceutical products of Ukrainian manufacturers: "O.L.KAR-AgroZooVet-Service", "Pharmaton", "Brovapharma", "Experimental production of the Institute of Epizootology", "Biopharm", and "Vetsintez". Imported products (62 %) were represented by Pharmacosmos, Merial, Koofavet , "Vugen B&G" , "Biovet Pulawy", "Interchem Verken De Adelaar", and "Bioveta". In general, the modern pharmaceutical market of veterinary drugs in Ukraine during 2017–2022 was sufficiently provided with antianemic drugs for pigs and mostly imported drugs. The percentage of antianemic drugs of Ukrainian production prevailed in 2020, however the imported drugs of this pharmacological group's was higher in 2022. It can be concluded that the drugs of non-Ukrainian production predominated among antianemic drugs in Ukraine during 2017-2022. Based on the obtained results, we can state that in Ukraine there is a need for the development and/or production of domestic anti-anemic drugs. They must be effective and ensure a reduction in the dependence of the national pharmaceutical market of drugs of this group on foreign manufacturers.

28 February 2020 in Ekonomika APK
Verified
Journal Article
Closed access
BDBohdan Dukhnytskyi
Bohdan Dukhnytskyi
VDVolodymyr Dukhnytskyi
Volodymyr Dukhnytskyi
Ekonomika APK : Зовнішньоекономічні відносини

2 November 2019 in Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences
Verified
Journal Article
Open access
PDF file
VDV. B. Dukhnitsky
V. B. Dukhnitsky
IDI. M. Derkach
I. M. Derkach
SDS. S. Derkach
S. S. Derkach
IFIgor Fritsky
Igor Fritsky
MPM. O. Plutenko
M. O. Plutenko
The article presents the results of studies of chronic toxicity of the Iron in the rare unconventional valence – IV. During long-term use of the Iron(IV) clathrochelate complexes for white rats we have established the dynamics of the body weight of rats, the relative coefficients of mass of the internal organs, the content of hemoglobin and morphological parameters of blood, biochemical parameters of blood serum of animals of this species. The daily drinking of solution of the Iron(IV) clathrochelate complexes at the doses of 500 and 1000 mg/kg b. w. resulted in a decrease in body weight, an increase in the relative indices of masses of liver and kidney, and a decrease in the relative indices of masses of  spleen and heart on 30th day. The hemoglobin content in the blood of rats of the experimental group was less than the control indicator by 3–47% (P < 0.05), which is evidence of inhibition of its synthesis under the influence of the Iron (IV) clathrochelatе. Changes in the morphological composition of the blood were characterized by marked leukocytopenia. The use of rats of a solution of the Iron (IV) clathrochelate complexes at doses of 500 and 1000 mg/kg b. w. caused the development of hypoproteinemia, hypercreatinemia and hyperurinemia. Iron(IV) clathrochelate complexes reduced alaninaminotransferase activity in the serum of rats of both experimental groups by 15–80% (P < 0.05); aspartataminotransferase activity increased significantly by day 10 and decreased by day 30; the activity of alkaline phosphatase was independent of the doses of the drug during the experimental period. The content of Calcium total, Phosphor inorganic and Iron in the serum of rats of the experimental groups was at the level of indicators in the animals of the control group. Consequently, comprehensive studies of the effects of solution of the Iron (IV) clathrochelate complexes at doses of 500 and 1000 mg/kg b. w. were performed for the first time with long-term administration to white rats, which revealed the main patterns of metabolic disorders and physiological functions.